This is a 33-year-old female, primigravida, who came in experiencing early labor. Patient is at 40 weeks gestation. The patient had been scheduled for a cesarean section due to breech presentation. This patient has had no significant problems during first, second, or third trimester. The patient’s past medical history is noncontributory. The patient’s LMP was 06/22/2021, placing her EDC at 04/05/2022. Ultrasounds were performed throughout the pregnancy and revealed adequate growth during the pregnancy and EDC remained technically the same. The patient’s initial blood work showed blood type to be A positive, VDRL was nonreactive, rubella titer indicated immunity, hepatitis B surface antigen (HbsAg) was negative, HIV screen was negative, GC and Chlamydia cultures were negative. Pap smear was normal. Her 1-hour glucose tolerance test was within normal parameters. The patient’s blood count also remained well within normal parameters. Her quad screen for maternal serum alpha-fetoprotein (MSAFP) was normal. Strep culture was likewise negative at 34–35 weeks. The patient, upon admission, was having contractions approximately every 4–5 minutes, moderate in intensity. The patient had no dilation; presenting part was still in a breech presentation, per bedside ultrasound; and the patient was therefore made ready for primary cesarean section. The patient was taken to surgery, where primary classical cesarean section was performed with delivery of a breech infant from left sacral anterior positioning, male weighing 6 pounds 10 ounces with Apgars 8 and 8 at 1 and 5 minutes. Placenta delivered intact. Membranes were removed. The patient tolerated the procedure quite well. Estimated blood loss was less than 600 mL. The patient has had an uneventful postoperative period. She is ambulating well and moving well at this time. The patient is passing gas, moving her bowels, and urinating well; moderate lochia is present; uterus is firm. The patient is discharged from the hospital, being given careful instructions to avoid douchi